Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-54861911 drug-drug interaction study with caffeine, midazolam, and tolbutamide in healthy men
NL-OMON41185Active, not recruiting
- Sponsor
- QPS
- Start
- Oct 2014
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of atabecestat in Alzheimer's disease (AD), sponsored by QPS. Primary endpoints: Pharmacokinetics, Safety and 1 more. Started Oct 2014; status: active, not recruiting.
02
Drugs
atabecestat
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NL-OMON41185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41185.